- Report
- January 2025
- 185 Pages
Global
From €3963EUR$4,500USD£3,484GBP
- Report
- December 2025
- 465 Pages
Global
From €5152EUR$5,850USD£4,529GBP
- Report
- September 2025
- 270 Pages
Global
From €4399EUR$4,995USD£3,867GBP
- Report
- October 2025
- 194 Pages
Global
From €3122EUR$3,545USD£2,745GBP
€3469EUR$3,939USD£3,050GBP
- Report
- October 2025
- 197 Pages
Global
From €3122EUR$3,545USD£2,745GBP
€3469EUR$3,939USD£3,050GBP
- Report
- April 2025
- 200 Pages
Global
From €3955EUR$4,490USD£3,476GBP
- Report
- July 2023
- 200 Pages
Global
From €4096EUR$4,650USD£3,600GBP
- Report
- October 2023
- 120 Pages
Global
From €5240EUR$5,950USD£4,606GBP
- Report
- October 2023
- 117 Pages
Global
From €3963EUR$4,500USD£3,484GBP
- Report
- March 2024
- 132 Pages
Global
From €837EUR$950USD£735GBP
- Report
- November 2021
- 527 Pages
Global
From €3523EUR$4,000USD£3,097GBP

The miRNA Sequencing market is a subset of the larger genomics market. It is focused on the sequencing of microRNAs, which are small, non-coding RNA molecules that regulate gene expression. miRNA sequencing is used to identify and quantify miRNAs in a sample, and can be used to study gene expression, disease diagnosis, and drug development.
miRNA sequencing is a rapidly growing field, with a variety of companies offering services and products. These include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, and QIAGEN. Show Less Read more